Literature DB >> 7605709

Comparison of the effects of intermittent and continuous administration of human parathyroid hormone(1-34) on rat bone.

T Uzawa1, M Hori, S Ejiri, H Ozawa.   

Abstract

We compared the effects of synthetic human parathyroid hormone (1-34) (hPTH[1-34]) on rat bones when administered by intermittent injection and by continuous infusion for 4 weeks. Continuous infusion of hPTH(1-34) caused a dose-dependent decrease in the dry weight of the femur and a hyperparathyroidism-like condition in the high-dose group (214 ng/kg/h). In this group, although bone morphology was quite abnormal, the metaphyseal trabecular bone volume increased, whereas the epiphyseal trabecular bone volume tended to decrease, enhancing both bone resorption and formation. The diaphyseal cortical bone of the tibia became markedly porous, and this appeared to be the main cause of the decrease in total bone weight. Conversely, the dry weight of the femur increased in a dose-dependent manner in the intermittent-injection groups. Neither porosity of the cortical bone nor abnormal morphology of the trabecular bone was observed. The volume of the metaphyseal trabecular bone increased while retaining its normal morphology. The epiphyseal trabecular bone formation obviously increased without increase in the number of osteoclasts. In other words, it was postulated that the total weight of bone increased because intermittent injection of hPTH(1-34) increased the trabecular bone volume without loss of the cortical bone volume. These results show that either mode of treatment with hPTH(1-34) continuously accelerated bone formation, whereas the continuous infusion was essential for persistently and markedly enhanced acceleration of bone resorption. It appears that the increase in bone volume with intermittent injection of hPTH(1-34) resulted from the prominent manifestation of its bone-formative action rather than from its bone-resorptive action.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7605709     DOI: 10.1016/8756-3282(95)90194-9

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  44 in total

1.  The calcium-sensing receptor complements parathyroid hormone-induced bone turnover in discrete skeletal compartments in mice.

Authors:  Yingben Xue; Yongjun Xiao; Jingning Liu; Andrew C Karaplis; Martin R Pollak; Edward M Brown; Dengshun Miao; David Goltzman
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-01-24       Impact factor: 4.310

2.  [The more efficacious acupoints of Zusanli and Sanyinjiao than that of non-acupoints on bone mass in osteopenic ovariectomized rats].

Authors:  Wen-ping Zhang; Masayuki Kanehara; Yan-jun Zhang; Zhi-feng Yu; Guo-xia Zhang; You-xin Yang; Yu-min Sun; Jian-mei Zhang; Torao Ishida
Journal:  Chin J Integr Med       Date:  2005-09       Impact factor: 1.978

3.  Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation.

Authors:  Makoto Okazaki; Sebastien Ferrandon; Jean-Pierre Vilardaga; Mary L Bouxsein; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

4.  Variation in the PTH2R gene is associated with age-related degenerative changes in the lumbar spine.

Authors:  Kristina Åkesson; Max Tenne; Paul Gerdhem; Holger Luthman; Fiona E McGuigan
Journal:  J Bone Miner Metab       Date:  2013-12-31       Impact factor: 2.626

5.  Parathyroid hormone exerts disparate effects on osteoblast differentiation depending on exposure time in rat osteoblastic cells.

Authors:  T Ishizuya; S Yokose; M Hori; T Noda; T Suda; S Yoshiki; A Yamaguchi
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

6.  Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone.

Authors:  L M Calvi; N A Sims; J L Hunzelman; M C Knight; A Giovannetti; J M Saxton; H M Kronenberg; R Baron; E Schipani
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

7.  Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis.

Authors:  U Lange; J Teichmann; J Strunk; U Müller-Ladner; K L Schmidt
Journal:  Osteoporos Int       Date:  2005-09-20       Impact factor: 4.507

8.  Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment.

Authors:  Emanuela Heller; Michelle A Hurchla; Jingyu Xiang; Xinming Su; Sara Chen; Jochen Schneider; Kyu-Sang Joeng; Marcos Vidal; Leah Goldberg; Hongju Deng; Mary C Hornick; Julie L Prior; David Piwnica-Worms; Fanxin Long; Ross Cagan; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2011-12-20       Impact factor: 12.701

9.  Inhibition of antigen presentation and T cell costimulation blocks PTH-induced bone loss.

Authors:  Brahmchetna Bedi; Jau-Yi Li; Francesco Grassi; Hesham Tawfeek; M Neale Weitzmann; Roberto Pacifici
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

10.  Transient modulation of calcium and parathyroid hormone stimulates bone formation.

Authors:  Andy B Chen; Kazumasa Minami; João F Raposo; Nariaki Matsuura; Masahiko Koizumi; Hiroki Yokota; Hugo G Ferreira
Journal:  Endocrine       Date:  2016-08-08       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.